Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

AgomAb Therapeutics Completes Euros 21m Series A Financing

argenx SE - American Depositary Shares (ARGX) 
Company Research Source: Business Wire
EUR 21m Series A secured with international investor syndicate co-led by V-Bio Ventures (Belgium) and Advent France Biotechnology (France), and joined by Boehringer Ingelheim Venture Fund (Germany), Omnes (France) and Pontifax (Israel) Senior appointments announced including Tim Knotnerus as Chief Executive Officer, Torsten Dreier as Chief Development Officer, and John Haurum as Chairman of the Board of Directors Exclusive license for HGF-mimetic SIMPLE Antibodies™, developed as a value-creating partnership with argenx SE (Netherlands) under its Innovative Access Program GHENT, Belgium--(BUSINESS WIRE)-- AgomAb Therapeutics N.V. (‘AgomAb’), a privately held Belgian biotherapeutics company developing agonistic antibodies for regeneration of damaged tissues, announces today that it has secured EUR 21m in a Series A financing round from a strong intern Show less Read more
Impact Snapshot
Event Time:
ARGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ARGX alerts
Opt-in for
ARGX alerts

from News Quantified
Opt-in for
ARGX alerts

from News Quantified